Authors:
Carini, DJ
Kaltenbach, RF
Liu, J
Benfield, PA
Boylan, J
Boisclair, M
Brizuela, L
Burton, CR
Cox, S
Grafstrom, R
Harrison, BA
Harrison, K
Akamike, E
Markwalder, JA
Nakano, Y
Seitz, SP
Sharp, DM
Trainor, GL
Sielecki, TM
Citation: Dj. Carini et al., Identification of selective inhibitors of cyclin dependent kinase 4, BIOORG MED, 11(16), 2001, pp. 2209-2211
Authors:
Sielecki, TM
Wityak, J
Liu, J
Mousa, SA
Thoolen, M
Wexler, RR
Olson, RE
Citation: Tm. Sielecki et al., Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists, BIOORG MED, 10(5), 2000, pp. 449-452
Authors:
Li, ZG
Liang, L
Harlow, RL
Foris, CM
Olson, RE
Sielecki, TM
Liu, J
Vickery, RD
Maurin, MB
Citation: Zg. Li et al., Crystalline versus amorphous content of Lumaxis (TM) analog XP280 using X-ray and electron diffraction methods, J PHARM SCI, 89(10), 2000, pp. 1237-1242
Authors:
Olson, RE
Sielecki, TM
Wityak, J
Pinto, DJ
Batt, DG
Frietze, WE
Liu, J
Tobin, AE
Orwat, MJ
Di Meo, SV
Houghton, GC
Lalka, GK
Mousa, SA
Racanelli, AL
Hausner, EA
Kapil, RP
Rabel, HR
Thoolen, MJ
Reilly, TM
Anderson, PS
Wexler, RR
Citation: Re. Olson et al., Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action, J MED CHEM, 42(7), 1999, pp. 1178-1192